MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PBYI made $228,371K in revenue. $31,111K in net income. Net profit margin of 13.62%.

Income Overview

Revenue
$228,371K
Net Income
$31,111K
Net Profit Margin
13.62%
EPS
$0.61
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Royalty

Income Statement
2025-12-31
2024-12-31
Total revenue
228,371 230,468
Cost of sales
58,157 64,404
Selling, general and administrative
70,847 80,163
Research and development
62,068 54,935
Total operating costs and expenses
191,072 199,502
Income from operations
37,299 30,966
Interest income
4,078 4,724
Interest expense
6,622 12,452
Other income
1,027 862
Total other expenses, net
-1,517 -6,866
Income before income taxes
35,782 24,100
Current income tax (expense)
1,426 897
Deferred income tax (expense) benefit
3,245 -7,075
Net income
31,111 30,278
Basic EPS
0.62 0.62
Diluted EPS
0.61 0.62
Basic Average Shares
50,011,485 48,648,701
Diluted Average Shares
50,653,283 49,100,433
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product$204,074K Royalty$24,297K Total revenue$228,371K (-0.91%↓ Y/Y)Income from operations$37,299K (20.45%↑ Y/Y)Total operating costsand expenses$191,072K (-4.23%↓ Y/Y)Income before incometaxes$35,782K (48.47%↑ Y/Y)Total other expenses,net-$1,517K (77.91%↑ Y/Y)Interest income$4,078K (-13.67%↓ Y/Y)Other income$1,027K (19.14%↑ Y/Y)Selling, general andadministrative$70,847K (-11.62%↓ Y/Y)Research and development$62,068K (12.98%↑ Y/Y)Cost of sales$58,157K (-9.70%↓ Y/Y)Net income$31,111K (2.75%↑ Y/Y)Deferred income tax(expense) benefit$3,245K (145.87%↑ Y/Y)Current income tax(expense)$1,426K (58.97%↑ Y/Y)Interest expense$6,622K (-46.82%↓ Y/Y)

PUMA BIOTECHNOLOGY, INC. (PBYI)

PUMA BIOTECHNOLOGY, INC. (PBYI)